DRUG REPURPOSING IN ANTIVIRAL RESEARCH: A REVIEW

VAISHNAVI R. MAHAJAN; SHYAMLILA B. BAVAGE; NANDKISHOR B. BAVAGE

DRUG REPURPOSING IN ANTIVIRAL RESEARCH: A REVIEW

Authors: VAISHNAVI R. MAHAJAN, SHYAMLILA B. BAVAGE, NANDKISHOR B. BAVAGE

Unique Paper ID: 153075
Volume: 8
Issue: 5
PageNo: 387-392

Keywords: Drug repurposing antiviral drug discovery viral infection.

Abstract:
Drug discovery and development are long, huge costly and time consuming processes. On an average it takes at least 10 years and cost 2.6 billion USD for successful drug discovery and approval for clinical use. Drug repurposing is a promising, fast and cost-effective method that can overcome traditional de novo drug discovery and development challenges of targeting various diseases. Drug repurposing is a process of identifying new therapeutic use for old and existing drugs. It is highly efficient strategy in the developing drug molecules with new pharmacological and therapeutic indications. In recent years, many pharmaceutical companies are developing new drugs with the discovery of novel biological targets by applying the drug repositioning strategy in drug discovery and the development processes. This strategy is an effective, time saving, low-cost and minimum risk of failure. It increases the therapeutic value of a drug and hence it increases the success rate. Thus, drug repositioning is an efficacious, successful and alternative approach to traditional drug discovery process. The repurposing approach has given many promising drug candidates for various viral infectious diseases like Ebola, Influenza, ZIKA, dengue, HIV infections and various other viral infectious diseases. The emergence of resistance to existing antiviral drugs and re-emerging viral infections are the biggest challenges in antiviral drug discovery process. The drug repurposing approach is an assuring strategy in finding new antiviral agents within a short period of time to overcome the challenges in antiviral therapy. In this review, we describe the most promising results of the drug repurposing approach in the treatment of various viral infectious diseases.

Download article

email to a friend

Cite This Article

ISSN: 2349-6002
Volume: 8
Issue: 5
PageNo: 387-392

DRUG REPURPOSING IN ANTIVIRAL RESEARCH: A REVIEW

Available:https://ijirt.org/Article?manuscript=153075

09 Nov, 2021

REVIEW ON DIABETES MELLITUS

08 Aug, 2021

RHINO-ORBITAL MUCORMYCOSIS ASSOCIATED WITH COVID-19

08 Aug, 2021

THE PRINCIPLES OF SKIN TISSUE ENGINEERING

08 Aug, 2021

A REVIEW ON LYME BORRELIOSIS

31 Jul, 2021

AWARENESS ABOUT BANNED DRUG

31 Jul, 2021

APPLICATION AND THE PRODUCTION OF RADIOPHARMACEUTICAL’S

30 Jul, 2021

ANTHELMINTIC ACTIVITY OF SOME MEDICINAL PLANTS

30 Jul, 2021

A REVIEW ON DRUMSTICK PLANTS (MORINGA OLEIFERA) MEDICAL USES AND NUTRITIONAL PROPERTIES

29 Jul, 2021

PHARMACOTHERAY OF HYPERTENSION

29 Jul, 2021

DIAGNOSTIC AND THERAPEUTIC STRATEGIES FOR COVID-19

Impact Factor
8.01 (Year 2024)

UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry